[Quality by design based high shear wet granulation process development for the microcrystalline cellulose]
Yao Xue Xue Bao = Acta Pharmaceutica Sinica
|June 30, 2015
Summary
This study established a design space for high shear wet granulation using quality by design (QbD). This ensures controlled granule size and bulk density for improved process robustness and flexibility.
Area of Science:
- Pharmaceutical Technology
- Chemical Engineering
- Materials Science
Background:
- High shear wet granulation is a critical unit operation in pharmaceutical manufacturing.
- Establishing a robust process requires understanding critical quality attributes (CQAs) and critical process parameters (CPPs).
- Quality by Design (QbD) principles provide a framework for systematic process development and control.
Purpose of the Study:
- To establish and validate the design space for a high shear wet granulation process.
- To identify critical quality attributes (CQAs) and critical process parameters (CPPs) for microcrystalline cellulose granules.
- To enhance process robustness and flexibility through QbD.
Main Methods:
- Utilized Quality by Design (QbD) principles for process development.
- Employed Plackett-Burman design for screening CPPs (e.g., mixing times, speeds, water addition, wet massing, drying time).
- Applied Central Composite Design for optimization and established the design space using polynomial regression models.
Main Results:
- Median granule size and bulk density identified as CQAs.
- Established a validated design space for high shear wet granulation.
- Achieved controlled granule size (250-355 μm) and bulk density (0.4-0.6 g/cm³).
- Models demonstrated good fit (P<0.05) and non-significant lack of fit (>0.1).
Conclusions:
- The established design space enhances the robustness and flexibility of the high shear wet granulation process.
- The QbD approach successfully defined process parameters for consistent granule quality.
- This methodology provides a reliable framework for controlling granule attributes in pharmaceutical manufacturing.


